SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-24-052976
Filing Date
2024-06-14
Accepted
2024-06-14 17:09:17
Documents
14
Period of Report
2024-06-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea0207933-8ka1_onconet.htm   iXBRL 8-K/A 38837
2 CONSULTING AGREEMENT, DATED JUNE 10, 2024, BETWEEN THE COMPANY AND KARINA FEDASZ ea020793301ex10-1_onconet.htm EX-10.1 57373
  Complete submission text file 0001213900-24-052976.txt   285149

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE onco-20240610.xsd EX-101.SCH 3042
4 XBRL LABEL FILE onco-20240610_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE onco-20240610_pre.xml EX-101.PRE 22377
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0207933-8ka1_onconet_htm.xml XML 4361
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Filer) CIK: 0001782107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-41294 | Film No.: 241045895
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)